Delivery Order SPE2DB20D3104-SPE2DB24FV8U9

Award Date 8/14/24
Potential Completion Date 8/15/24
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,285.98 fixed-price delivery order is for the supply of 4,566,600 units of Losartan Potassium 100 mg tablets, a medication commonly used to treat high blood pressure and heart failure. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,142.12 firm fixed-price delivery order is for the supply of 1,000 units of Losartan Potassium 100 mg tablets, a medication used to treat high blood pressure and heart failure. The contract has an ultimate completion date of March 3, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $8,981.18, is for the delivery of 4,566,250 units of Losartan Potassium 100 mg tablets, a medication used to treat high blood pressure and heart failure. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of October 29, 2024. This award is not associated with a...
This federal contract award SPE2DB22D1103|SPE2DB24FTDH2 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,406.35 firm-fixed-price delivery order is for the supply of 1,000 units of Losartan Potassium 100 mg tablets, a medication used to treat high blood pressure and heart failure. The award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,926.24 firm-fixed-price delivery order is for Losartan Potassium 100 mg tablets, a medication used to treat high blood pressure and heart failure. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the...
This federal contract award (SPE2DB20D7059|SPE2DB25FPWG6) was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,122.48 firm fixed-price delivery order is for the supply of 1,000 tablets of Losartan Potassium 25 mg, a medication used to treat high blood pressure and heart failure. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen...
This federal contract award is a Delivery Order valued at $1,909.50 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Losartan Potassium 100 mg tablets, a medication used to treat high blood pressure and heart failure. The award is not designated as a set-aside contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,337.57 firm fixed-price delivery order is for the supply of Losartan Potassium 100 mg tablets. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $4,139.26, is for the delivery of 100 mg Losartan Potassium tablets, a medication used to treat high blood pressure and heart failure. The contract is a Firm Fixed Price Delivery Order with a completion date of December 12, 2024. No set-aside designation was used for this award. AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,039.31 firm fixed price delivery order is for the supply of Losartan Potassium 100 mg tablets, a cardiovascular medication, to support military healthcare programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
  • SPE2DB20D3104
    Indefinite Delivery Contract
  • SPE2DB20D3104-SPE2DB24FV8U9
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,678.42 firm fixed-price delivery order is for the supply of 50 mg Losartan Potassium tablets, a medication used to treat high blood pressure and heart failure.

The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

The contract does not have a set-aside designation, indicating it was awarded through open competition. The 2-year delivery order will run through August 2024, with performance in Conshohocken, Pennsylvania.

Generated 2/27/25, 1:12 PM